Company Registration No. 09347024 (England and Wales)
APEX MEDICAL CONSULTING LTD
Unaudited accounts
for the year ended 30 November 2017
APEX MEDICAL CONSULTING LTD
Unaudited accounts
Contents
APEX MEDICAL CONSULTING LTD
Company Information
for the year ended 30 November 2017
Director
Dr Omolaja Sharafadeen Kassim
Company Number
09347024 (England and Wales)
Registered Office
77 LONDON LANE
BROMLEY
KENT
BR1 4HF
Accountants
LIBRA ASSOCIATES (UK) LIMITED
20 - 22 BROCKLEY CROSS
LONDON
SE4 2AA
APEX MEDICAL CONSULTING LTD
Statement of financial position
as at
30 November 2017
Tangible assets
857
1,143
Cash at bank and in hand
13,786
3,652
Creditors: amounts falling due within one year
(12,200)
(15,489)
Net current assets
13,241
8,041
Called up share capital
1
1
Profit and loss account
14,097
9,183
Shareholders' funds
14,098
9,184
For the year ending 30 November 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the Board on 4 August 2018.
Dr Omolaja Sharafadeen Kassim
Director
Company Registration No. 09347024
APEX MEDICAL CONSULTING LTD
Notes to the Accounts
for the year ended 30 November 2017
APEX MEDICAL CONSULTING LTD is a private company, limited by shares, registered in England and Wales, registration number 09347024. The registered office is 77 LONDON LANE, BROMLEY, KENT, BR1 4HF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% Straightline
The accounts are presented in £ sterling.
4
Tangible fixed assets
Computer equipment
Cost or valuation
At cost
At 30 November 2017
1,429
At 30 November 2016
1,143
APEX MEDICAL CONSULTING LTD
Notes to the Accounts
for the year ended 30 November 2017
Other debtors
11,655
19,878
6
Creditors: amounts falling due within one year
2017
2016
Taxes and social security
11,575
14,839
7
Transactions with related parties
The company was under the control of Dr Omolaja Sharafadeen Kassim who owns 100% of the issued share capital. Dr Omolaja Sharafadeen Kassim received a dividend of £35,000 (2016: £55,000).
8
Average number of employees
During the year the average number of employees was 1 (2016: 1).